{"schema_version":"1","generated_at":"2026-11-07T07:50:27.103Z","data_as_of":null,"url":"https://www.findmykol.com/kol/roderich-schwarz","json_url":"https://www.findmykol.com/kol/roderich-schwarz/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"roderich-schwarz","name":"Roderich Schwarz","credential":"MD, PhD","specialty":"Surgical Oncology","specialty_raw":"Surgical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Buffalo","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1871679589","orcid":"0000-0003-1968-5057","openalex":"A5006708086"},"summary":"Roderich Schwarz is an Oncology physician. OpenAlex indexes 295 publications with 7,343 citations (h-index 48).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":295,"cited_by_count":7343,"h_index":48,"latest_activity_year":2024,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2024,"amount_usd":17.11,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871679589"},{"payer":"Ethicon US, LLC","program_year":2021,"amount_usd":11.72,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871679589"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1871679589","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer","year":2019,"journal":"Cancer Letters","source_url":"https://doi.org/10.1016/j.canlet.2019.05.037","status":"verified"},{"title":"A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis","year":2017,"journal":"Oncogene","source_url":"https://doi.org/10.1038/onc.2017.108","status":"verified"},{"title":"CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer","year":2015,"journal":"Cancer Letters","source_url":"https://doi.org/10.1016/j.canlet.2015.01.033","status":"verified"},{"title":"A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases","year":2015,"journal":"Annals of Surgical Oncology","source_url":"https://doi.org/10.1245/s10434-015-4579-z","status":"verified"},{"title":"Profile of nintedanib in the treatment of solid tumors: the evidence to date","year":2015,"journal":"OncoTargets and Therapy","source_url":"https://doi.org/10.2147/ott.s78805","status":"verified"}],"source":"works"},"contact":{"address_1":"ELM AND CARLTON STREETS","city":"Buffalo","state":"NY","zip":"142634810","phone":"716-845-2300","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1871679589","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-02-10","provider_certified":"2021-02-10","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}